Türk Kızılay Kan Hizmetleri Genel Müdürlüğü
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü is the Turkish Red Crescent's national blood services directorate, operating 18 regional blood centers and 68 donation centers across all 81 provinces of Turkey to collect, test, and distribute blood, apheresis, plasma, and stem cell donations free of charge to hospitals and patients under Law No. 5624.
- Company typePrivate
- Founded1983
- HeadquartersAnkara, Türkiye
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Türk Kızılay Kan Hizmetleri Genel Müdürlüğü does
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü is the General Directorate of Blood Services of the Turkish Red Crescent (Türkiye Kızılay Derneği), a public-benefit humanitarian association established as a separate directorate in 1983 with blood service roots dating to 1921. It is the legally designated national blood supply authority of Turkey under Law No. 5624, operating 18 Regional Blood Centers, 68 Blood Donation Centers, and approximately 300 daily mobile collection points covering all 81 provinces. In 2025, the organization collected 3,041,278 units of blood, the highest annual figure in its history, with 1,246,400 additional units in the first five months of 2026. The technical backbone is a blood-banking automation system implemented in 2006, an integrated quality management system certified to ISO 9001:2015 and ISO 10002:2018, and nucleic acid amplification testing (NAT) added October 30, 2014 for HIV, Hepatitis B, Hepatitis C, and Syphilis screening.
Core service lines include voluntary whole-blood donation, apheresis (platelet) donation, plasma donation, and stem cell coordination through TÜRKÖK, a national registry jointly operated with the Ministry of Health since November 7, 2013, which holds 1,231,392 active donor candidates and has completed 8,500 stem cell collections. Supporting assets include the iOS/Android Türk Kızılay Mobil Kan Bağışı application, the kanver.org appointment platform, university (Hedef 25), school (Okulumda Kanpanya Var), youth (Genç Kızılay Kan Elçileri), and mukhtar-led neighborhood (Mahallenin Gücü) donor acquisition programs, the Blood Donation League sports-fan campaign, and a thalassemia/sickle-cell patient-donor matching project (BİS).
Blood and blood components are provided free of charge to hospitals and patients as a public service; no revenue is generated from blood product distribution. Operations are funded through government support, donations, and the parent Türk Kızılay's humanitarian funding base, with no external investors or venture capital involved. Forward strategy centers on the Protürk Plasma Drug Facility, a joint venture with South Korea's SK Plasma in Çubuk, Ankara (groundbreaking June 2026), intended to manufacture albumin, immunoglobulin, and clotting factors domestically and reduce an estimated €450 million in annual plasma-derived medicine imports.
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü firmographics
Firmographics- Name
- Türk Kızılay Kan Hizmetleri Genel Müdürlüğü
- Legal name
- Türk Kızılay Kan Hizmetleri Genel Müdürlüğü
- Website
- https://kanver.org
- Company type
- Private
- Founded year
- 1983
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Türk Kızılay Kan Hizmetleri Genel Müdürlüğü is the Turkish Red Crescent's national blood services directorate, operating 18 regional blood centers and 68 donation centers across all 81 provinces of Turkey to collect, test, and distribute blood, apheresis, plasma, and stem cell donations free of charge to hospitals and patients under Law No. 5624.
- Ownership category
- akta.pro rank
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü industry classification
Industry- Product category
- Blood Banking Services
- NAICS
- Blood and Organ Banks (621991)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Blood, Organ & Tissue Donation Organizations (BPAGACAJ)
- akta.pro secondary industries
- Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH), Plasma Collection & Donor Services (Plasmapheresis Centers) (HLAIAHAH), Plasma-Derived Therapeutics (immunoglobulins, albumin, clotting factors) (HLAAAAAI)
Keywords
Where Türk Kızılay Kan Hizmetleri Genel Müdürlüğü is headquartered
LocationHeadquarters
- HQ city
- Ankara
- HQ country
- Türkiye
- HQ region
- Europe
Offices3 records
Markets served
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure
Revenue model
- Blood and Blood Products (Public Service — No Revenue): Türk Kızılay provides blood and blood components free of charge to patients. No fee is charged to patients or their relatives for blood component therapy. This is a public service mandate under Law No. 5624 and does not generate revenue.
Go-to-market motion1 record
Distribution channels5 records
Marketing channels9 records
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü product offering
Product offeringCore offering
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü is the national blood services authority of Turkey, operating 18 Regional Blood Centers and 68 Blood Donation Centers to collect, test, process, store, and distribute whole blood, erythrocytes, platelets, and plasma free of charge to hospitals. It also coordinates the national hematopoietic stem cell donor registry (TÜRKÖK) with over 1.2 million registered donors for bone marrow transplantation, and is establishing domestic plasma-derived pharmaceutical production through the Protürk facility.
Product overview
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü operates as Turkey's national blood services authority, managing a comprehensive blood supply system through its network of 18 Regional Blood Centers and 68 Blood Collection Facilities. The organization's product portfolio centers on four core service areas: blood donation (including appointments at collection points and mobile units), apheresis services for platelet collection, stem cell donation coordination through the TÜRKÖK national registry, and plasma services. Supporting these core operations are digital platforms including the online blood donation appointment system, the mobile application for iOS/Android, the Blood Donation League gamification initiative, and targeted programs like the 'Biz İyilik Severiz' thalassemia patient-donor matching project. The organization also coordinates international cooperation through its role in the World Bone Marrow Registry and manages educational initiatives including the Hedef 25 university awareness program.
Differentiator
Problem solved
Functional benefit
Brands
- TÜRKÖK: Türkiye Kök Hücre Koordinasyon Merkezi – Turkey Stem Cell Coordination Center. A joint initiative with the Ministry of Health for hematopoietic stem cell donor recruitment, HLA registry, and bone marrow bank database.
- Türk Kızılay Mobil Kan Bağışı
- Genç Kızılay Kan Elçileri (Young Red Crescent Blood Ambassadors)
- Okulumda Kanpanya Var
- Biz İyilik Severiz (BİS)
- Mahallenin Gücü Kan Bağışıyla Büyür
- Protürk Plazma İlaç Tesisi
Products and services
- Kan Bağışı (Whole Blood Donation Service) Voluntary whole blood collection from donors at regional centers, donation points, and mobile collection teams; blood is tested (including NAT screening for HIV, Hepatitis B, Hepatitis C, Syphilis), processed into erythrocyte, platelet, and plasma components, and supplied free of charge to hospitals and transfusion centers for patient treatment.
- Aferez Bağışı (Apheresis Donation Service) Apheresis procedure that separates and collects specific blood components (primarily platelets) from donors while returning other components to the donor. Performed at regional blood centers to support patients requiring targeted platelet transfusions.
- Plazma Bağışı (Plasma Donation Service) Plasma collection from donors for domestic manufacturing of plasma-derived pharmaceuticals (Albumin, Immunoglobulin, clotting factors) through the Protürk Plasma Drug Facility, reducing Turkey's annual import dependency by approximately €450 million.
- TÜRKÖK Stem Cell Donor Coordination Service National hematopoietic stem cell donor registry and matching service operated jointly with the Ministry of Health; recruits volunteer donors, performs HLA tissue typing, maintains a database of over 1.2 million donor candidates, and has completed 36,905 patient-donor matchings and 8,500 stem cell collections since inception.
- Türk Kızılay Mobil Kan Bağışı Uygulaması (Mobile Blood Donation App) Mobile application available on iOS and Android for donor registration, appointment booking at blood donation points, blood type card access, and SMS notifications when donated blood is used by a patient.
Quantifiable outcome
- 3,041,278 units of blood collected in 2025 — highest annual figure in the organization's history
- +7 more outcomes
Companies that use Türk Kızılay Kan Hizmetleri Genel Müdürlüğü
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles2 records
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core, major and minor.
- SK Plasma (Güney Koreli)coreTürk Kızılay and South Korean SK Plasma are collaborating to build the Protürk Plasma Drug Facility in Çubuk, Ankara. The facility will produce plasma-derived medicines (Albumin, Immunoglobulin, Clotting Factors) domestically, reducing Turkey's import dependency by approximately €450 million annually and creating ~300 jobs.
- T.C. Sağlık Bakanlığı (Ministry of Health)coreTÜRKÖK (Türkiye Kök Hücre Koordinasyon Merkezi) is a joint initiative between Türk Kızılay and the Ministry of Health for bone marrow donor recruitment, HLA typing, registry management, and stem cell collection coordination. Over 1.2 million donor candidates are registered.
- T.C. Milli Eğitim Bakanlığı (Ministry of National Education)majorNationwide voluntary blood donor education and recruitment program in schools. Since 2006, 890,292 units of blood collected through 20,632 school-based teams. The Okulumda Kanpanya Var project extends this to kindergarten through secondary school levels.
- Talasemi Federasyonu ve Kan Hastalıkları FederasyonuminorPartnership for the Biz İyilik Severiz (BİS) project targeting thalassemia and sickle cell anemia patients. Creates a dedicated donor pool of 40,783 people and 4,063 regular donors for matched blood transfusions to reduce alloimmunization.
- TİKA (Türk İşbirliği ve Koordinasyon Ajansı Başkanlığı)minorInternational cooperation through which Türk Kızılay shared its blood donation expertise with Bosnia and Herzegovina. Training program for 24 healthcare workers from 10 cities on donor recruitment strategies and field applications.
- Şahinbey BelediyesiminorAnnual blood donation campaign in Gaziantep's Şahinbey district, now in its 17th year. 65,880 units of blood collected over 17 years. Municipality provides organizational support and promotional gifts for donors.
- Various Municipalities and Public Institutionsminor82 institutional partnerships with corporations, municipalities, and government bodies for organized blood donation campaigns, venue provision, and promotional support.
Scale indicators9 records
Recent moves10 records
Expansion highlights6 records
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü competitors and assessment
Company assessmentDirect peers
- NHS Blood and Transplant (NHSBT): Statutory UK authority for blood, organs, and stem cell supply with nationwide collection infrastructure and integrated donor registries; directly comparable to Kızılay's mandated national role and full-service blood and cellular therapy coordination.
- Be The Match (National Marrow Donor Program): Operates the largest global hematopoietic stem cell donor registry and coordinates bone marrow transplants; directly comparable to TÜRKÖK in registry-based stem cell donor recruitment, HLA typing, and patient-donor matching.
- Italian National Blood Center (CNS / Centro Nazionale Sangue): Italy's national authority coordinating regional blood services and transfusion medicine under the Ministry of Health; directly comparable as a national coordinator of blood collection, quality standards, and stem cell registries.
- Établissement Français du Sang (EFS): France's national, publicly-operated blood service with mandated monopoly on blood collection; directly comparable in regulated national monopoly structure, plasma-derived medicine coordination with LFB, and full geographic coverage.
- American Red Cross Biomedical Services: Operates the largest U.S. blood collection and distribution network under the American Red Crescent equivalent nonprofit structure; directly comparable as a Red Cross/Red Crescent national blood service with voluntary donor mobilization, regional centers, and stem cell services.
- Australian Red Cross Lifeblood: Australian Red Cross-affiliated national blood service operating collection centers across Australia; directly comparable as a Red Cross national blood operator with voluntary donor model and integrated apheresis and stem cell services.
- Canadian Blood Services: Canada's national, non-profit blood operator funded by provincial governments; directly comparable in mandate (national blood supply authority), regional center structure, and stem cell registry (OneMatch, merged into CBS).
- German Red Cross Blood Donor Service: Largest blood collection organization in Germany under the German Red Cross umbrella; directly comparable as a Red Cross national blood service operating regional centers, voluntary donor model, and plasma-derived therapy partnerships.
Regional players
- Hellenic National Blood Center (EKEA): Greek national blood service operating under similar public-mandate model; comparable as a regional Southern European national blood service with voluntary donor mobilization and hospital distribution.
Broad incumbents
- CSL Plasma: World's largest plasma collection network and parent of CSL Behring, a global plasma-derived therapeutics manufacturer; comparable as a major incumbent in plasma collection and fractionation that Kızılay's Protürk facility is positioned to compete with domestically.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü social profiles
Digital presenceTürk Kızılay Kan Hizmetleri Genel Müdürlüğü compliance and trust
Trust signalCompliance3 records
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü financial estimates
Financial estimateRevenue estimate
Valuation estimate
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü leadership team
Management profileNumber of profiles
Profiles2 records
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü subsidiaries and ownership
Company hierarchySubsidiaries1 record
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Türk Kızılay Kan Hizmetleri Genel Müdürlüğü
What does Türk Kızılay Kan Hizmetleri Genel Müdürlüğü do?
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü is the national blood services authority of Turkey, operating 18 Regional Blood Centers and 68 Blood Donation Centers to collect, test, process, store, and distribute whole blood, erythrocytes, platelets, and plasma free of charge to hospitals. It also coordinates the national hematopoietic stem cell donor registry (TÜRKÖK) with over 1.2 million registered donors for bone marrow transplantation, and is establishing domestic plasma-derived pharmaceutical production through the Protürk facility.
Is Türk Kızılay Kan Hizmetleri Genel Müdürlüğü a public or private company?
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Türk Kızılay Kan Hizmetleri Genel Müdürlüğü founded?
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü was founded in 1983. It employs 51 to 100 people.
Where is Türk Kızılay Kan Hizmetleri Genel Müdürlüğü based?
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü is headquartered in Ankara, Türkiye, in the Europe region.
How does Türk Kızılay Kan Hizmetleri Genel Müdürlüğü make money?
One revenue line is on record: blood and Blood Products (Public Service — No Revenue).
Who are Türk Kızılay Kan Hizmetleri Genel Müdürlüğü's main competitors?
Direct peers on record are NHS Blood and Transplant (NHSBT), Be The Match (National Marrow Donor Program), Italian National Blood Center (CNS / Centro Nazionale Sangue), Établissement Français du Sang (EFS), American Red Cross Biomedical Services, Australian Red Cross Lifeblood, Canadian Blood Services and German Red Cross Blood Donor Service. Hellenic National Blood Center (EKEA) is listed as a regional player. CSL Plasma is listed as a broad incumbent.
Does Türk Kızılay Kan Hizmetleri Genel Müdürlüğü have an API?
No public API is recorded for Türk Kızılay Kan Hizmetleri Genel Müdürlüğü.
What industry is Türk Kızılay Kan Hizmetleri Genel Müdürlüğü in?
Türk Kızılay Kan Hizmetleri Genel Müdürlüğü's product category is Blood Banking Services. Its primary akta.pro industry code is BPAGACAJ, Blood, Organ & Tissue Donation Organizations, with a secondary code of HLAHAAAH, Blood Bank, Transfusion Medicine & Immunohematology. Its NAICS code is 621991 and its SIC code is 8071.